SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

被引：355

作者：

Corbett, Kizzmekia S. ^{[1
]}

Edwards, Darin K. ^{[2
]}

Leist, Sarah R. ^{[3
]}

Abiona, Olubukola M. ^{[1
]}

Boyoglu-Barnum, Seyhan ^{[1
]}

Gillespie, Rebecca A. ^{[1
]}

Himansu, Sunny ^{[2
]}

Schafer, Alexandra ^{[3
]}

Ziwawo, Cynthia T. ^{[1
]}

DiPiazza, Anthony T. ^{[1
]}

Dinnon, Kenneth H. ^{[3
]}

Elbashir, Sayda M. ^{[2
]}

Shaw, Christine A. ^{[2
]}

Woods, Angela ^{[2
]}

Fritch, Ethan J. ^{[4
]}

Martinez, David R. ^{[3
]}

Bock, Kevin W. ^{[5
]}

Minai, Mahnaz ^{[5
]}

Nagata, Bianca M. ^{[5
]}

Hutchinson, Geoffrey B. ^{[1
]}

Wu, Kai ^{[2
]}

Henry, Carole ^{[2
]}

Bahl, Kapil

Garcia-Dominguez, Dario ^{[2
]}

Ma, LingZhi ^{[2
]}

Renzi, Isabella ^{[2
]}

Kong, Wing-Pui ^{[1
]}

Schmidt, Stephen D. ^{[1
]}

Wang, Lingshu ^{[1
]}

Zhang, Yi ^{[1
]}

Phung, Emily ^{[1
,6
]}

Chang, Lauren A. ^{[1
]}

Loomis, Rebecca J. ^{[1
]}

Altaras, Nedim Emil ^{[2
]}

Narayanan, Elisabeth ^{[2
]}

Metkar, Mihir ^{[2
]}

Presnyak, Vlad ^{[2
]}

Liu, Cuiping ^{[1
]}

Louder, Mark K. ^{[1
]}

Shi, Wei ^{[1
]}

Leung, Kwanyee ^{[1
]}

Yang, Eun Sung ^{[1
]}

West, Ande ^{[3
]}

Gully, Kendra L. ^{[3
]}

Stevens, Laura J. ^{[7
]}

Gully, Kendra L. ^{[3
]}

Wang, Nianshuang ^{[8
]}

Wrapp, Daniel ^{[8
]}

Doria-Rose, Nicole A. ^{[1
]}

Stewart-Jones, Guillaume ^{[2
]}

机构：

[1] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[2] Moderna Inc, Cambridge, MA USA

[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA

[4] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA

[5] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[6] George Washington Univ, Inst Biomed Sci, Washington, DC USA

[7] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA

[8] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA

[9] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

来源：

NATURE | 2020年 / 586卷 / 7830期

关键词：

MERS-COV; SPIKE; INFLUENZA; IMMUNOGENICITY; PROTECTION; VIRUS; RSV;

D O I：

10.1038/s41586-020-2622-0

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have led to the development of mutations that stabilize Betacoronavirus spike proteins in the prefusion state, improving their expression and increasing immunogenicity(1). This principle has been applied to design mRNA-1273, an mRNA vaccine that encodes a SARS-CoV-2 spike protein that is stabilized in the prefusion conformation. Here we show that mRNA-1273 induces potent neutralizing antibody responses to both wild-type (D614) and D614G mutant(2) SARS-CoV-2 as well as CD8(+) T cell responses, and protects against SARS-CoV-2 infection in the lungs and noses of mice without evidence of immunopathology. mRNA-1273 is currently in a phase III trial to evaluate its efficacy.

引用

页码：567 / +

页数：21

共 50 条

[21] Immune imprinting and SARS-CoV-2 vaccine design
Wheatley, Adam K.
Fox, Annette
Tan, Hyon-Xhi
Juno, Jennifer A.
Davenport, Miles P.
Subbarao, Kanta
Kent, Stephen J.
TRENDS IN IMMUNOLOGY, 2021, 42 (11) : 956 - 959
[22] INADEQUATE SARS-COV-2 ANTIBODY RESPONSE TO MRNA SARS-COV-2 VACCINE IN ADOLESCENT KIDNEY TRANSPLANT RECIPIENTS
Loop, L.
Crane, C.
Anterasian, C.
Geng, B.
Ingulli, E.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S7 - S8
[23] The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
Tolan, Nicole, V
Sherman, Amy C.
Zhou, Guohai
Nabel, Katherine G.
Desjardins, Michael
Melanson, Stacy
Kanjilal, Sanjat
Moheed, Serina
Kupelian, John
Kaufman, Richard M.
Ryan, Edward T.
LaRocque, Regina C.
Branda, John A.
Dighe, Anand S.
Abraham, Jonathan
Baden, Lindsey R.
Charles, Richelle C.
Turbett, Sarah E.
MICROBIOLOGY SPECTRUM, 2022, 10 (02):
[24] Rational design of a single-component mRNA vaccine against orthopoxvirus and SARS-CoV-2
Yilong Yang
Xiaofan Zhao
Yu Li
Xiaodong Zai
Xinyi Wang
Yue Zhang
Xiaolin Wang
Peng Lv
Jun Zhang
Lihua Hou
Junjie Xu
Wei Chen
Science China(Life Sciences), 2024, 67 (06) : 1311 - 1313
[25] Rational design of a single-component mRNA vaccine against orthopoxvirus and SARS-CoV-2
Yang, Yilong
Zhao, Xiaofan
Li, Yu
Zai, Xiaodong
Wang, Xinyi
Zhang, Yue
Wang, Xiaolin
Lv, Peng
Zhang, Jun
Hou, Lihua
Xu, Junjie
Chen, Wei
SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (06) : 1311 - 1313
[26] Skin reactions to mRNA-1273 SARS-CoV-2 vaccine
Wang, Ruei-Lin
Huang, Li-Yen
Yang, Chung-Chi
Hsieh, Chung-Yueh
Wu, Kuo-An
Chan, Jenq-Shyong
Wu, Kun-Lin
Shyu, Hann-Yen
Kao, Yung-Hsi
Shang, Shih-Ta
Hsiao, Po-Jen
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2022, 115 (12) : 878 - 878
[27] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, Lindsey R.
El Sahly, Hana M.
Essink, Brandon
Kotloff, Karen
Frey, Sharon
Novak, Rick
Diemert, David
Spector, Stephen A.
Rouphael, Nadine
Creech, C. Buddy
McGettigan, John
Khetan, Shishir
Segall, Nathan
Solis, Joel
Brosz, Adam
Fierro, Carlos
Schwartz, Howard
Neuzil, Kathleen
Corey, Larry
Gilbert, Peter
Janes, Holly
Follmann, Dean
Marovich, Mary
Mascola, John
Polakowski, Laura
Ledgerwood, Julie
Graham, Barney S.
Bennett, Hamilton
Pajon, Rolando
Knightly, Conor
Leav, Brett
Deng, Weiping
Zhou, Honghong
Han, Shu
Ivarsson, Melanie
Miller, Jacqueline
Zaks, Tal
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05): : 403 - 416
[28] SARS-CoV-2: Efficacy and Safety of the mRNA-1273 Vaccine
Metzger, Leandra
PNEUMOLOGIE, 2022, 76 (03): : 154 - 154
[29] Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine
Rodriguez-Martin, Minerva
Corriols-Noval, Patricia
Lopez-Simon, Eugenia
Morales-Angulo, Carmelo
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2022, 40 (01): : 47 - 48
[30] SARS-CoV-2 mRNA vaccine: Sometimes life needs a boost
Lo, Carson Ka-Lok
Kumar, Deepali
TRANSPLANT INFECTIOUS DISEASE, 2023,

← 1 2 3 4 5 →